Grocery chain Weis Markets has reported sales growth for the second quarter despite unfavorable conditions impacting its pharmacy segment.

For the 13 weeks ended June 27, total revenue rose 4.6 per cent to $1.28 billion, with comparable store sales up 2.3 per cent.

Management noted that pharmacy revenue growth was negatively affected by approximately $10.71 million from pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions, which took effect on January 1.

Net income for the period decreased 9.6 per cent to $22.86 million.

“Customers remain focused on affordability and value, which continues to impact how they shop our stores,” said Weis Markets’ chairman, president and CEO Jonathan Weis. 

“To support them, we have increased our investment in promotions and targeted loyalty marketing while maintaining strong in-stock conditions and a consistent shopping experience.”

For the first half, sales were up 4.6 per cent on a reported basis and 2.2 per cent on a comparable basis. Net income grew 13 per cent to $50.71 million.

Founded in 1912, Weis Markets operates 202 stores in Pennsylvania, Maryland, Delaware, New Jersey, New York, West Virginia and Virginia.